543616 logo

Trident Lifeline BSE:543616 Stock Report

Last Price

₹165.00

Market Cap

₹1.9b

7D

6.0%

1Y

12.4%

Updated

25 Apr, 2024

Data

Company Financials

Trident Lifeline Limited

BSE:543616 Stock Report

Market Cap: ₹1.9b

543616 Stock Overview

Trident Lifeline Limited, a pharmaceutical company, engages in the manufacture and marketing of finished dosages in India, Ghana, Kenya, Nigeria, Cameroon, Venezuela, and internationally.

543616 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance3/6
Financial Health4/6
Dividends0/6

Trident Lifeline Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Trident Lifeline
Historical stock prices
Current Share Price₹165.00
52 Week High₹239.70
52 Week Low₹123.25
Beta0
1 Month Change5.33%
3 Month Change-17.09%
1 Year Change12.44%
3 Year Changen/a
5 Year Changen/a
Change since IPO52.57%

Recent News & Updates

Recent updates

Shareholder Returns

543616IN PharmaceuticalsIN Market
7D6.0%1.4%2.8%
1Y12.4%57.2%46.6%

Return vs Industry: 543616 underperformed the Indian Pharmaceuticals industry which returned 55.9% over the past year.

Return vs Market: 543616 underperformed the Indian Market which returned 46.4% over the past year.

Price Volatility

Is 543616's price volatile compared to industry and market?
543616 volatility
543616 Average Weekly Movement8.2%
Pharmaceuticals Industry Average Movement5.9%
Market Average Movement6.9%
10% most volatile stocks in IN Market10.1%
10% least volatile stocks in IN Market4.2%

Stable Share Price: 543616 has not had significant price volatility in the past 3 months.

Volatility Over Time: 543616's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
201436Shravan Patelwww.tridentlifeline.com

Trident Lifeline Limited, a pharmaceutical company, engages in the manufacture and marketing of finished dosages in India, Ghana, Kenya, Nigeria, Cameroon, Venezuela, and internationally. The company offers pharmaceutical products in the form of tablets, capsules, liquid orals, oral dry powders, and topical and dental preparations; and nutraceutical tablets, capsules, liquids, sachets, oral sprays, and effervescent tablets, as well as ice gels, mouthwashes, pastes, and toothpastes. The company was incorporated in 2014 and is based in Surat, India.

Trident Lifeline Limited Fundamentals Summary

How do Trident Lifeline's earnings and revenue compare to its market cap?
543616 fundamental statistics
Market cap₹1.90b
Earnings (TTM)₹71.01m
Revenue (TTM)₹364.41m

26.7x

P/E Ratio

5.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
543616 income statement (TTM)
Revenue₹364.41m
Cost of Revenue₹226.58m
Gross Profit₹137.83m
Other Expenses₹66.83m
Earnings₹71.01m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Apr 27, 2024

Earnings per share (EPS)6.18
Gross Margin37.82%
Net Profit Margin19.49%
Debt/Equity Ratio12.5%

How did 543616 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.